In Vitro Assessment of Anti-inflammatory Effect of Apigenin on Renal Cell Inflammation

• Published in: Clinical and experimental health sciences (Online) 2022-09, Vol.12 (3), p.739-745
• Main Authors: ÖZSOY, Selen, YARIM, Gül Fatma
• Format: Article
• Language: English
• Subjects: Inflammation; Tumor necrosis factor-TNF
• ISSN: 2459-1459; 2459-1459
• DOI: 10.33808/clinexphealthsci.1018335

Objective: This study aimed to evaluate in vitro effect of apigenin on anti – and pro-inflammatory cytokines including interleukin-6 (IL-6), IL-10, tumor necrosis factor-alpha (TNF-α), and transforming growth factor-beta (TGF-β) levels in an in vitro model of renal cell inflammation induced with lipopolysaccharide (LPS). Methods: For the in vitro renal cell inflammation model, the African green monkey kidney cell line (Vero) was used. Four groups as NC (without any treatment), LPS (Vero cells treated with 10 μg/mL of LPS for 4 hours), API (Vero cells treated with 5 μg/mL of apigenin for 12 hours), and LPS+API (Vero cells treated with 5 μg/mL of apigenin for 12 hours + 10 μg/mL of LPS for 4 hours) was formed. The non-cytotoxic dose of apigenin in Vero cells was evaluated by a cell count test. IL-6, IL-10, TNF-α, and TGF-β concentrations in the cell culture medium were measured by enzyme-linked immunosorbent assay kits. All analyses were performed in four repetitions. Results: IL-6, IL-10, TNF-α, and TGF-β concentrations of the LPS group increased compared to NC, API, and LPS+API groups (p